ANXA10 is specifically expressed in gastric epithelial cells and is frequently downregulated in human gastric cancer, making this an appropriate driver for gastric-specific genetic manipulation (Lu et al., 2011; Ishikawa et al., 2020). Here, ANXA10 is linked to gastric cancer.